TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

Zealand Pharma Collaborates with Benchling to Advance Engineered Peptide Medicine Research and Development

Wednesday, April 24, 2024

Today, Benchling announced that Zealand Pharma A/S has opted for the Benchling R&D Cloud as its central platform for scientific data, collaboration, and insights. Zealand teams will employ the Benchling R&D Cloud to capture, analyze, and exchange stability data internally and with external contract manufacturing organization (CMO) partners in accordance with GxP standards.

Ludo Otterbein, Zealand Pharma's Head of IT, stressed the importance of traceability and verification in their fast-paced research environment. Otterbein mentioned, "Scientists and partners can't afford to be hindered by fragmented systems or inconsistent data. Integrating the lab and automating data capture and sharing through technology is paramount." Zealand expects that Benchling will provide them with a digital infrastructure that enables safe and confident expansion into new use cases and partnerships.

As a Nasdaq Copenhagen 25 (OMX C25) Index company, Zealand Pharma aims to revolutionize lives with advanced peptide medicines, particularly targeting metabolic diseases like obesity. Operating across numerous CMOs and partners necessitates real-time access to data and secure, compliant information exchange. Zealand will implement Benchling as a GxP-compliant platform for their development teams, encompassing process development. The adoption of Benchling will empower Zealand scientists with enhanced data control and visibility, streamlined data transfer processes, and user-friendly reporting and analytics, including seamless integrations with tools like JMP.

Bob Burke, General Manager of Benchling EMEA, emphasized Zealand's recognition of the pivotal role of a robust digital strategy in the competitive biotech arena. Burke stated, "Benchling R&D Cloud equips Zealand with cutting-edge technology to streamline and expedite its development, compliance, and partner interactions. We eagerly anticipate further collaboration with Zealand and supporting their innovative endeavors."

Zealand Pharma is scheduled to present at Benchling's upcoming Nordic Digital Science & Innovation Day event, slated for May 30, 2024, at the Tivoli Congress Center in Copenhagen. Registration for the event is currently open.

 

Source: prnewswire.com

patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit